Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Sees Significant Increase in Short Interest

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totalling 600,500 shares, an increase of 19.1% from the June 15th total of 504,000 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 6,005.0 days.

Recordati Industria Chimica e Farmaceutica Stock Down 0.7 %

Shares of RCDTF stock opened at $51.60 on Monday. The firm’s 50 day moving average price is $51.60 and its two-hundred day moving average price is $50.81. Recordati Industria Chimica e Farmaceutica has a fifty-two week low of $51.60 and a fifty-two week high of $51.98.

Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last posted its earnings results on Thursday, May 9th. The company reported $0.85 EPS for the quarter. The firm had revenue of $659.94 million for the quarter. Analysts expect that Recordati Industria Chimica e Farmaceutica will post 2.81 EPS for the current year.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.